Skip to content
LexBuild

Meeting of the Advisory Council on Blood Stem Cell Transplantation

---
identifier: "/us/fr/2019-09434"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Meeting of the Advisory Council on Blood Stem Cell Transplantation"
title_number: 0
title_name: "Federal Register"
section_number: "2019-09434"
section_name: "Meeting of the Advisory Council on Blood Stem Cell Transplantation"
positive_law: false
currency: "2019-05-08"
last_updated: "2019-05-08"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2019-09434"
document_type: "notice"
publication_date: "2019-05-08"
agencies:
  - "Health and Human Services Department"
  - "Health Resources and Services Administration"
fr_citation: "84 FR 20153"
fr_volume: 84
fr_action: "Notice; correction."
---

#  Meeting of the Advisory Council on Blood Stem Cell Transplantation

**AGENCY:**

Health Resources and Services Administration (HRSA), HHS.

**ACTION:**

Notice; correction.

**SUMMARY:**

The Advisory Council on Blood Stem Cell Transplantation (ACBSCT) meeting has been rescheduled due to unforeseen circumstances and will now be held on Tuesday, July 2, 2019, from 10:00 a.m.-4:00 p.m. Eastern Time. The meeting will be held by webinar and conference call. The webinar link, conference call-in number, agenda, and instructions for registration will be posted 15 business days before the meeting on the ACBSCT website at *https://bloodcell.transplant.hrsa.gov/about/advisory_council/meetings/index.html.*

**FOR FURTHER INFORMATION CONTACT:**

Robert Walsh, Designated Federal Officer, at the Healthcare Systems Bureau, Division of Transplantation, HRSA, 5600 Fishers Lane, 8W60, Rockville, Maryland 20857; 301-443-6839; or *[email protected].*

*New meeting date:* Tuesday, July 2, 2019, rather than May 7, 2019, as previously announced.

Amy P. McNulty,

Acting Director, Division of the Executive Secretariat.